VJNeurology is committed to improving our service to you

Share this video  

VJNeurology is committed to improving our service to you

EAN 2020 | TERIKIDS study: teriflunomide in pediatric patients with relapsing MS

Tanuja Chitnis • 24 May 2020
EAN 2020
Multiple Sclerosis and Related Disorders Teriflunomide
TERIKIDS

Tanuja Chitnis, MD, FAAN, Massachusetts General Hospital, Boston, MA, discusses the TERIKIDS trial (NCT02201108) looking at the efficacy and safety of teriflunomide in pediatric patients with relapsing forms of multiple sclerosis (MS). This interview was recorded during an online conference call with The Video Journal of Neurology (VJNeurology).

More from Tanuja Chitnis

1:34
Serum neurofilament levels are associated with health outcomes and resource use in MS
Tanuja Chitnis • 23 Feb 2021
4:18
Determining the optimal treatment strategy in MS
Tanuja Chitnis • 23 Feb 2021
4:18
Determining the optimal treatment strategy in MS
Tanuja Chitnis • 23 Feb 2021
1:08
Pediatric MS: where does research need to move?
Tanuja Chitnis • 24 May 2020

Related Videos

3:20
Why is important to pay attention to cognition in multiple sclerosis?
Claire Riley • 26 Feb 2021
6:12
Estrogen treatments to negate menopausal effects on disability severity in women with MS
Rhonda Voskuhl • 25 Feb 2021
4:06
Are COVID-19 vaccines safe and effective in the setting of MS DMTs?
Amit Bar-Or • 25 Feb 2021
1:39
DMT use and clinical characteristics in MS by race and ethnicity
Carlos Pérez • 25 Feb 2021
The content of VJNeurology is intended for healthcare professionals